NCT00618163View on ClinicalTrials.gov

Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Inflammation
Interventions
DRUG

Meloxicam

Trial Locations (1)

77042

Novum Pharmaceutical Research Services, Houston

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00618163 - Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter